Finance

Lists
Why is CUV down 4.20%?
Dive Deeper
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$ 7.07
-4.20%
(-0.31) 1D
10-р сарын 22, 16:11:00 (GMT+11)  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Open
A$ 7.25
High
A$ 7.25
Low
A$ 6.90
Mkt. cap
356.94 сая
Avg. vol.
147.33 мян
Volume
348.82 мян
Dividend
0.71%
Quarterly dividend
A$ 0.01
Ex-dividend date
2026 оны 9-р сарын 3
P/E ratio
10.58
52-wk high
A$ 13.48
52-wk low
A$ 6.62
EPS
A$ 0.67
Shares outstanding
50.49 сая
No. of employees
16
Open
A$ 7.25
High
A$ 7.25
Low
A$ 6.90
Mkt. cap
356.94 сая
Avg. vol.
147.33 мян
Volume
348.82 мян
Dividend
0.71%
Quarterly dividend
A$ 0.01
Ex-dividend date
2026 оны 9-р сарын 3
P/E ratio
10.58
52-wk high
A$ 13.48
52-wk low
A$ 6.62
EPS
A$ 0.67
Shares outstanding
50.49 сая
No. of employees
16
News stories
From web sources and news partners
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
18.47 сая
18.47 сая
28.55 сая
28.55 сая
Cost of goods sold
2.28 сая
2.28 сая
5.62 сая
5.62 сая
Cost of revenue
2.28 сая
2.28 сая
5.62 сая
5.62 сая
Research and development expenses
1.70 сая
1.70 сая
7.35 сая
7.35 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.96 сая
6.96 сая
2.83 сая
2.83 сая
Operating expense
9.42 сая
9.42 сая
9.42 сая
9.42 сая
Total operating expenses
11.71 сая
11.71 сая
15.04 сая
15.04 сая
Operating income
6.76 сая
6.76 сая
13.51 сая
13.51 сая
Other non operating income
-
-
322.45 мян
322.45 мян
EBT including unusual items
7.29 сая
7.29 сая
16.54 сая
16.54 сая
EBT excluding unusual items
7.29 сая
7.29 сая
16.54 сая
16.54 сая
Income tax expense
2.07 сая
2.07 сая
4.80 сая
4.80 сая
Effective tax rate
28.39%
28.39%
29.03%
29.03%
Other operating expenses
-1.24 мян
-1.24 мян
1.24 мян
1.24 мян
Net income
5.22 сая
5.22 сая
11.74 сая
11.74 сая
Net profit margin
28.28%
28.28%
41.11%
41.11%
Earnings per share
-
-
-
-
Interest and investment income
2.63 сая
2.63 сая
3.87 сая
3.87 сая
Interest expense
-1.28 сая
-1.28 сая
-
-
Net interest expenses
1.35 сая
1.35 сая
3.87 сая
3.87 сая
Depreciation and amortization charges
250.02 мян
250.02 мян
-250.02 мян
-250.02 мян
EBITDA
7.01 сая
7.01 сая
13.55 сая
13.55 сая
Gain or loss from assets sale
-
-
28.62 мян
28.62 мян
AI content may include mistakes. Learn more
Google аппс